The Systemic Immune-Inflammation Index (SII) predicted severe coronary lesions with a sensitivity of 86.2% and specificity of 87.3% in patients with stable angina pectoris.
Does the Systemic Immune-Inflammation Index (SII) predict the severity of coronary artery disease in patients with stable angina pectoris?
The Systemic Immune-Inflammation Index is an inexpensive and easily measurable biomarker that significantly correlates with coronary artery disease severity in patients with stable angina.
Absolute Event Rate: 0% vs 0%
predicted the severe coronary lesion with a sensitivity of 86.2% and specificity of 87.3%. The SII, an inexpensive and easily measurable laboratory variable, was significantly associated with the severity of CAD and high SxS in patients with stable angina pectoris.
Candemir et al. (Tue,) reported a other. The Systemic Immune-Inflammation Index (SII) predicted severe coronary lesions with a sensitivity of 86.2% and specificity of 87.3% in patients with stable angina pectoris.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: